Duvelisib (Compound)

Synonyms:Duvelisib, 1201438-56-3, IPI-145, INK-1197, (S)-3-(1-((9H-Purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one, IPI 145, UNII-610V23S0JI, IPI145, (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one, INK-1147, IPI-145 (INK1197), Duvelisib (IPI-145, INK1197), 610V23S0JI, 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one, Duvelisib hydrate, Copiktra (TN), 1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-, Duvelisib [USAN], Duvelisib [USAN:INN], IPI-145;INK1197, 1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-, INK1197, DUVELISIB [INN], DUVELISIB [MI], Duvelisib (USAN/INN), Duvelisib (IPI-145), DUVELISIB [WHO-DD], SCHEMBL153543, GTPL7795, DUVELISIB [ORANGE BOOK], CHEMBL3039502, SCHEMBL18343557, SCHEMBL19670020, SCHEMBL20580104, DTXSID80152697, CHEBI:131169, AMY24208, BCP07042, EX-A1562, BDBM50193013, MFCD15144635, NSC772469, s7028, AKOS022186370, AKOS037515795, IPI-145, INK 1197, Duvelisib, CCG-268854, CS-0888, DB11952, NSC-772469, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-1(2H)-isoquinolinone, NCGC00351482-01, AC-30239, AS-16309, compound 4904 [Patent US8193182], HY-17044, SW219822-1, D10555, EN300-18167128, Q27077129, IPI-145 pound>>INK1197; IPI 145; IPI145; INK-1197; INK 1197, 8-Chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one, 8-chloro-2-phenyl-3-[(1S)-1-[(9H-purin-6-yl)amino]ethyl]-1,2-dihydroisoquinolin-1-one

Pubchem:PUBCHEM:50905713

Id:46e7aa83-53b4-5b9c-85d9-859c2df7a9da

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Duvelisib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Duvelisib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Duvelisib.

Results found

Linked to

	Label	Description
	BRD-K93468883-001-02-0 Substance (Entity type)	A Substance
	duvelisib (da236d8f-9c47-4ddd-b86e-0034fd930822) Collection (Entity type)	Metadatata for duvelisib
	DCSTRUCT ID 05296 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05296; PubChem_CID:50905713, FILE=drugcentral_drug_05296.json)
	Duvelisib positively regulates TRPS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duvelisib positively regulates ASPM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duvelisib indication Small Lymphocytic Lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Duvelisib positively regulates LUM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duvelisib negatively regulates PTPN6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Duvelisib bioactivity Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Duvelisib negatively regulates CDKN1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS